Home » Topics » Regulatory » Patents

Patents
RSS

MRI contrast agents in development at Nycomed Imaging

Sep. 15, 1998

Antigestagenic steroid esters patented by Schering AG

Sep. 15, 1998

Adrenergic agents for BPH described by Abbott in patent literature

Sep. 15, 1998

Orally active anticoagulants in early development at Gedeon Richter

Sep. 14, 1998

Inhibitors of ICE activity described by Vertex

Sep. 14, 1998

Preparation and use of peptide bradykinin B2 receptor agonists described by Fournier

Sep. 14, 1998

Antiplatelet compounds developed by Merck & Co.

Sep. 14, 1998

Inhibitors of sPLA2 claimed by Lilly for septic shock, etc.

Sep. 14, 1998

Synthelabo compounds act as 5-HT receptor ligands

Sep. 14, 1998

Fujisawa scientists synthesize new series of vasopressin antagonists

Sep. 10, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 30, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 29, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...